Company intelligence / Profile preview

Prodimed

Neuilly-en-Thelle, Oise, France

Ownership: Private
Development stage: Other

Overview

Prodimed is a French company specializing primarily in the design, manufacturing, and distribution of single-use medical devices for gynecology, vascular surgery, intensive care, dental/plastic surgery. It also operates a separate business line focused on evidence-based nutritional programs targeting obesity prevention and weight management. The company has sponsored at least one early-phase clinical trial in oncology with its small molecule candidate PDM08 for advanced solid tumors; this program reached Phase 1 completion but no further development is publicly reported.

Therapeutic areas: CardiovascularEndocrinologyOtherWomen's HealthOncology
Modalities: Small moleculeMedical deviceNutrition-based therapy/program
Industry: Surgical Medical Devices

Partnerships

Laboratoire CCD (gynecology/reproduction collaboration since the 1980s)

Beyond the preview

Go deeper on Prodimed.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Prodimed.

Explore the full profile